Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rafi Bamdad Group is an investment entity founded and led by Rafi Bamdad since 1987. It focuses on investing in innovative biosciences and technology ventures. The group's portfolio includes several prominent biotech and health startups such as Mammoth Biosciences (CRISPR diagnostics), Haystack Sciences Corporation, Mantra Bio, Chimera Bioengineering, TurnCare™, Boost Biomes, Vave Health, Pyze Inc., and Naked Biome. These investments span a range of clinical stages from early development to commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rafi Bamdad Group.